INVESTOR ALERT: Law Offices of Howard G Smith Continues Investigation of FibroGen Inc. (FGEN) on Behalf of Investors

Published Apr 07 2021 at 7:32 PM GMT
  • Law Offices of Howard G Smith continues its investigation on behalf of FibroGen Inc.
  • ("Fibrogen" or the "Company") (NASDAQ: FGEN) investors concerning the Company and its officers' possible violations of federal securities laws.
  • On April 6, 2021, after the market closed, FibroGen issued a statement "provid[ing] clarification of certain prior disclosures of US primary cardiovascular safety analyses from the roxadustat Phase 3 program for the treatment of anemia of chronic kidney disease (?CKD').
  • Specifically, the Company stated that.


  • Published Apr 7, 2021 7:32 PM GMT